The outlook of companies tied to iconic drugs like Viagra presents a nuanced investment scenario . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key territories has introduced significant risk . Investors are now assessing the impact of lower-cost alternatives, diminis